|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00004483191 |
| 005 |
20191202143748.0 |
| 008 |
930419s1993 nyua b 001 0 eng c |
| 010 |
|
|
|a 93008117
|
| 020 |
|
|
|a 0824788931
|
| 035 |
|
|
|a (OCoLC)28116402
|
| 035 |
|
|
|9 AAF9778MS
|
| 035 |
|
|
|z (UtOrBLW)18683
|
| 035 |
|
|
|a 30821
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d EET
|d UtOrBLW
|
| 049 |
|
|
|a TMVM
|c 1
|
| 050 |
0 |
0 |
|a RM301.27
|b .D79 1993
|
| 060 |
0 |
0 |
|a QV 771
|b D7948 1993
|
| 069 |
0 |
|
|a 9307616
|
| 082 |
0 |
0 |
|a 615/.1901
|2 20
|
| 245 |
0 |
0 |
|a Drug safety assessment in clinical trials /
|c edited by Gene Sogliero-Gilbert.
|
| 264 |
|
1 |
|a New York :
|b Dekker,
|c [1993]
|
| 264 |
|
4 |
|c ©1993
|
| 300 |
|
|
|a x, 437 pages :
|b illustrations ;
|c 24 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|b txt
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|b nc
|
| 490 |
1 |
|
|a Statistics, textbooks and monographs ;
|v v. 138
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Preclinical drug safety evaluation / James T. Mayne -- Adverse drug events in clinical trials / Deborah S. Kirby -- Laboratory testing in clinical trials / Deborah S. Kirby -- Drug Research in the elderly / Piet M. Hooymans and Robert Janknegt -- Drug assessment in critical illness / M.I. Bowden and J.F. Bion -- Laboratory data in multicenter trials: monitoring, adjustment, and summarization / Lawrence K. Oliver and Christy Chuang-Stein -- Genie score: a multivariate assessment of laboratory abnormalities / Gene Sogliero-Gilbert, Lonni Zubkoff-Schulz and Naitee Ting -- Laboratory parameters and drug safety / Norman E. Pitts -- Unified approach to the analysis of safety data in clinical trials / Christy Chuang-Stein and Noel R. Mohberg -- Use of hazard functions in safety analysis / David S. Salsburg -- Meta-analysis of drug safety data / Gary G. Koch ... [et al.] -- Design and analysis considerations for safety data, particularly adverse events / Karl E. Peace -- Clinical trial adverse drug experience reporting requirements in the major countries: one manufacturer's approach / Max W. Talbott and Ellen D. Kelso.
|
| 505 |
0 |
|
|a (cont.) Safety surveillance / Norman E. Pitts -- Postmarketing surveillance: applications and limitations with special reference to the fluoroquinolones / Robert Janknegt and Yechiel A. Hekskter.
|
| 650 |
|
2 |
|a Clinical Trials as Topic
|x methods.
|
| 650 |
|
2 |
|a Drug Evaluation
|x methods.
|
| 700 |
1 |
|
|a Sogliero-Gilbert, Gene,
|d 1925-
|
| 830 |
|
0 |
|a Statistics, textbooks and monographs ;
|v v. 138.
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 16e6c0d6-05eb-31cc-a72c-b4822240e555
|i 816d605e-00ce-33c9-9ad8-5325f64be395
|t 0
|
| 952 |
f |
f |
|p ric
|a Texas A&M University
|b Rellis Campus
|c Joint Library Facility
|d Remote Storage
|t 0
|e QV 771 D7948 1993
|h National Library of Medicine classification
|i unmediated -- volume
|m 3238901045440
|
| 998 |
f |
f |
|a QV 771 D7948 1993
|t 0
|l Remote Storage
|